Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy
2019 ◽
Vol 24
(5)
◽
pp. 554-556
2019 ◽
Vol 24
(5)
◽
pp. 546-553
◽
2015 ◽
Vol 3
(4)
◽
pp. 123-126
◽
2020 ◽
Vol 12
◽
pp. 175883592097813